Balchem Corporation Capital Expenditure for the Trailing 12 Months (TTM) ending March 31, 2025: USD -28.75 M

Balchem Corporation Capital Expenditure is USD -28.75 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -18.05% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Balchem Corporation Capital Expenditure for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -35.08 M, a -29.49% change year over year.
  • Balchem Corporation Capital Expenditure for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -49.75 M, a 20.20% change year over year.
  • Balchem Corporation Capital Expenditure for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -41.39 M, a 19.13% change year over year.
  • Balchem Corporation Capital Expenditure for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -34.75 M, a 37.34% change year over year.
Key Data
Date Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Depreciation And Amortization